← Leaderboards
David Masopust
University Of Minnesota
$22,435,964
Attributed
$25,424,184
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.1M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,802,671 · 12
By mechanism
R01$20,505,162 · 7
P01$10,459,640 · 2
DP2$2,265,000 · 1
R37$1,142,970 · 1
UM1$429,899 · 1
Top collaborators
- David Andrew Largaespada5 shared
- David J Odde5 shared
- Ashley T. Haase4 shared
- Ryan Langlois4 shared
- Rama Rao Amara1 shared
- Eric Hunter1 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Kelsey Wanhainen$160,826
- Katie Lynne Anderson$176,536
- Laura Jane Niedernhofer$20,513,980
- Mark J Osborn$748,457
- Ameeta Kelekar$2,437,775
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteCellsTissuesImmunityT Memory CellResponseInfectionVaccinationImmune ResponseSiteMemoryVaccinesMalignant NeoplasmsMucous MembranePathogenCd8b1 GeneImmune SystemEnvironmentProgramsMaintenanceIn VivoAntigensCytokineLymphocyte
Grant awards (52)
Integrated Immune Engineering for Poor Prognosis Cancers$1,907,279
P01 · FY2025 · CA
Resident Memory T Cells$699,919
R01 · FY2025 · AI · contact PI
Using an in vivo multi-lifetime model to test mechanisms of aging$636,687
R01 · FY2025 · AG · contact PI
Mucosal T cell memory to pathogens$571,485
R37 · FY2025 · AI · contact PI
Effect of aging and senescent cells$541,381
P01 · FY2025 · AI · contact PI
Integrated Immune Engineering for Poor Prognosis Cancers$1,811,915
P01 · FY2024 · CA
Using an in vivo multi-lifetime model to test mechanisms of aging$649,679
R01 · FY2024 · AG · contact PI
New mouse model to better predict human immunity to influenza vaccination and infection$615,280
R01 · FY2024 · AI · contact PI
Mucosal T cell memory to pathogens$571,485
R37 · FY2024 · AI · contact PI
Effect of aging and senescent cells$539,772
P01 · FY2024 · AI · contact PI
Repurposing TRM for tumor immunotherapy$465,651
R01 · FY2024 · CA · contact PI
B and T Cell Biology of Protection from and Eradication of SIV/SHIV Infection$429,899
UM1 · FY2024 · AI
Integrated Immune Engineering for Poor Prognosis Cancers$1,869,132
P01 · FY2023 · CA
New mouse model to better predict human immunity to influenza vaccination and infection$615,280
R01 · FY2023 · AI · contact PI
Resident Memory T Cells$604,558
R01 · FY2023 · AI · contact PI
Repurposing TRM for tumor immunotherapy$480,356
R01 · FY2023 · CA · contact PI
Mucosal T cell memory to pathogens$477,507
R01 · FY2023 · AI · contact PI
Integrated Immune Engineering for Poor Prognosis Cancers$1,869,132
P01 · FY2022 · CA
New mouse model to better predict human immunity to influenza vaccination and infection$615,280
R01 · FY2022 · AI · contact PI
Resident Memory T Cells$604,558
R01 · FY2022 · AI · contact PI
Repurposing TRM for tumor immunotherapy$480,356
R01 · FY2022 · CA · contact PI
Mucosal T cell memory to pathogens$477,507
R01 · FY2022 · AI · contact PI
Repurposing TRM for tumor immunotherapy$5,185
R01 · FY2022 · CA · contact PI
Integrated Immune Engineering for Poor Prognosis Cancers$1,921,029
P01 · FY2021 · CA
New mouse model to better predict human immunity to influenza vaccination and infection$615,280
R01 · FY2021 · AI · contact PI
Resident Memory T Cells$604,558
R01 · FY2021 · AI · contact PI
Repurposing TRM for tumor immunotherapy$554,986
R01 · FY2021 · CA · contact PI
Mucosal T cell memory to pathogens$477,507
R01 · FY2021 · AI · contact PI
Resident Memory T Cells$601,077
R01 · FY2020 · AI · contact PI
Repurposing TRM for tumor immunotherapy$487,080
R01 · FY2020 · CA · contact PI
Mucosal T cell memory to pathogens$474,940
R01 · FY2020 · AI · contact PI
Repurposing TRM for tumor immunotherapy$30,380
R01 · FY2020 · CA · contact PI
Mucosal T Cell Memory to Pathogens$380,000
R01 · FY2019 · AI · contact PI
Mucosal T Cell Memory to Pathogens$733,267
R01 · FY2018 · AI · contact PI
Regulation of T cell immunity within the female reproductive tract$475,237
R01 · FY2018 · AI · contact PI
Regulation of T cell immunity within the female reproductive tract$475,237
R01 · FY2017 · AI · contact PI
Mucosal T Cell Memory to Pathogens$380,000
R01 · FY2017 · AI · contact PI
Regulation of T cell immunity within the female reproductive tract$475,237
R01 · FY2016 · AI · contact PI
Mucosal T Cell Memory to Pathogens$380,000
R01 · FY2016 · AI · contact PI
Regulation of T cell immunity within the female reproductive tract$475,237
R01 · FY2015 · AI · contact PI
Mucosal T Cell Memory to Pathogens$190,000
R01 · FY2015 · AI · contact PI
Regulation of T cell immunity within the female reproductive tract$475,237
R01 · FY2014 · AI · contact PI
Mucosal T Cell Memory to Pathogens$373,725
R01 · FY2014 · AI · contact PI
Impact of Extraordinarily Large Numbers of SIV-specific CD8 T Cells on Vaginal Tr$672,484
R01 · FY2013 · AI · contact PI
Mucosal T Cell Memory to Pathogens$351,302
R01 · FY2013 · AI · contact PI
Impact of Extraordinarily Large Numbers of SIV-specific CD8 T Cells on Vaginal Tr$736,366
R01 · FY2012 · AI · contact PI
Mucosal T Cell Memory to Pathogens$373,725
R01 · FY2012 · AI · contact PI
Impact of Extraordinarily Large Numbers of SIV-specific CD8 T Cells on Vaginal Tr$752,108
R01 · FY2011 · AI · contact PI
Mucosal T Cell Memory to Pathogens$373,725
R01 · FY2011 · AI · contact PI
Impact of Extraordinarily Large Numbers of SIV-specific CD8 T Cells on Vaginal Tr$781,164
R01 · FY2010 · AI · contact PI
Mucosal T Cell Memory to Pathogens$377,500
R01 · FY2010 · AI · contact PI
Maximizing CD8 T Cells for Protection$2,265,000
DP2 · FY2009 · OD · contact PI